ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 97 filers reported holding ARATANA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 20.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $138,000 | +43.8% | 26,800 | 0.0% | 0.01% | +60.0% |
| Q1 2019 | $96,000 | -61.8% | 26,800 | -34.6% | 0.01% | -64.3% |
| Q4 2018 | $251,000 | -35.1% | 41,000 | -38.1% | 0.01% | -12.5% |
| Q3 2018 | $387,000 | +44.9% | 66,218 | +5.6% | 0.02% | +60.0% |
| Q2 2018 | $267,000 | -49.1% | 62,729 | -47.3% | 0.01% | -44.4% |
| Q1 2018 | $525,000 | -16.1% | 119,100 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $626,000 | -20.1% | 119,100 | -6.8% | 0.02% | -30.8% |
| Q3 2017 | $783,000 | -15.8% | 127,800 | -0.6% | 0.03% | -29.7% |
| Q2 2017 | $930,000 | +212.1% | 128,633 | +209.5% | 0.04% | +85.0% |
| Q4 2016 | $298,000 | -63.1% | 41,563 | -51.9% | 0.02% | -57.4% |
| Q3 2016 | $808,000 | +48.0% | 86,338 | 0.0% | 0.05% | +9.3% |
| Q2 2016 | $546,000 | +112.5% | 86,338 | +85.5% | 0.04% | +168.8% |
| Q1 2016 | $257,000 | +1.6% | 46,538 | +2.6% | 0.02% | -54.3% |
| Q4 2015 | $253,000 | -38.3% | 45,338 | +10.9% | 0.04% | +218.2% |
| Q3 2014 | $410,000 | – | 40,867 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
| Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
| MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
| AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
| First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
| Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
| Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
| AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
| Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |